Press Release

China region is the largest supplier of Avian Influenza Vaccines, with a production market share nearly 49%.

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.

The global average price of Avian Influenza Vaccines is in the decreasing trend, from XX K USD/K doses to XX USD/K doses. With the situation of global economy, prices will be in decreasing trend in the following five years.

The classification of Avian Influenza Vaccines includes H5 Avian Influenza Vaccines, H9 Avian Influenza Vaccines, and other Avian Influenza Vaccines, and the proportion of H5 Avian Influenza Vaccines is about XX%, and the proportion is in decreasing trend.

Avian Influenza Vaccines is widely used in Chicken, Duck & Goose and Other birds. The most proportion of Avian Influenza Vaccines is used in chicken, and the production proportion is about XX%.

China region is the largest supplier of Avian Influenza Vaccines, with a production market share nearly 49%. Asia (Ex. China) is the second largest supplier of Avian Influenza Vaccines, enjoying production market share nearly XX%.

China is the largest consumption place, with a consumption market share nearly XX%. Following China, Asia (Ex. China) is the second largest consumption place with the consumption market share of XX%.

Market competition is intense. Merial, QYH Biotech, DHN, HVRI, CEVA, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The global Avian Influenza Vaccines market is valued at XX million US$ and will reach 130 million US$ by the end of 2025, growing at a CAGR of XX% during 2018-2025.

Global Avian Influenza Vaccines Market Research Report 2018 is a professional and in-depth study and available exclusively through Trusted Business Insights. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets in this 97 pages report.

This market report provides in-depth analytics of the Avian Influenza Vaccines industry including definition, classification, application and industry chain structure. The report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share, and contact information.

Request for a Sample PDF of Avian Influenza Vaccines research report

Avian Influenza Vaccines market report includes an in-depth analysis of the competitive landscape of this business vertical, constituting companies like:

Merial
CEVA
Zoetis
Elanco (Lohmann )
Merck Animal Health
Avimex Animal Health

Products Segmentation, this report displays the production, revenue, price, market share, and growth rate of each type as below:

Type H5
Type H9
Other
By Industrial Application, the market can be split into:

Chicken
Duck & Goose
Other

Market Segment by Regions includes:

  • North America (the USA, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, and Italy)
  • Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
  • South America
  • Middle East and Africa.

Browse contents of Global Avian Influenza Vaccines Market Research Report 2018

Contacts

Trusted Business Insights
Jessica Wang
Media & Marketing Executive
[email protected]
US: +1 646 568 9797
UK: +44 330 808 0580